KPRX
NASDAQ · Pharmaceuticals
Kiora Pharmaceuticals Inc
$2.60
+0.13 (+5.26%)
Open$2.49
Previous Close$2.47
Day High$2.65
Day Low$2.48
52W High$3.29
52W Low$1.76
Volume—
Avg Volume31.2K
Market Cap11.21M
P/E Ratio—
EPS$-2.62
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,028.5% upside
Current
$2.60
$2.60
Target
$29.34
$29.34
$16.75
$29.34 avg
$32.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 15.53M | 8.57M | 1.95M |
| Net Income | 3.48M | 1.73M | 336.4K |
| Profit Margin | 22.4% | 21.3% | 17.3% |
| EBITDA | 4.31M | 2.26M | 564.5K |
| Free Cash Flow | — | — | 437.5K |
| Rev Growth | +81.3% | +81.3% | -4.0% |
| Debt/Equity | — | — | 0.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |